Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ocular medications in children

D K Wallace1, P G Steinkuller

  • 1Department of Ophthalmology, University of North Carolina at Chapel Hill 27599-7040, USA.

Clinical Pediatrics
|November 24, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An international comparison of retinopathy of prematurity grading performance within the Benefits of Oxygen Saturation Targeting II trials.

Eye (London, England)·2017
Same author

Preoperative issues in adult strabismus.

The American orthoptic journal·2010
Same author

Laser treatment for ROP.

Ophthalmology·2001
Same author

Poor postnatal weight gain: a risk factor for severe retinopathy of prematurity.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus·2000
Same author

Prognostic significance of vascular dilation and tortuosity insufficient for plus disease in retinopathy of prematurity.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus·2000
Same author

Ophthalmic manifestations of Angelman syndrome.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus·2000
Same journal

Effect of Preferred Language on Pediatric Rapid Response Activation and Subsequent Intensive Care Utilization.

Clinical pediatrics·2026
Same journal

Documented Caregiver Report of Wheezing at Home is Associated With Decreased Length of Pediatric Asthma Hospitalizations.

Clinical pediatrics·2026
Same journal

The Rash That Will Not Go Away.

Clinical pediatrics·2026
Same journal

Virtual Reality Education for Hospitalized Pediatric Patients Improves Intrinsic Motivation: A Prospective, Randomized Crossover Study.

Clinical pediatrics·2026
Same journal

Pediatric Invasive Group A Streptococcus Characteristics Before, During, and After COVID-19.

Clinical pediatrics·2026
Same journal

Lichen Sclerosus: A Common but Often Overlooked Condition in Pediatric Patients.

Clinical pediatrics·2026
See all related articles

Pediatricians and ophthalmologists use various eye medications for children. Careful risk-benefit evaluation and monitoring for side effects are crucial when prescribing ophthalmic drugs to pediatric patients.

Area of Science:

  • Ophthalmology
  • Pediatrics
  • Pharmacology

Background:

  • Ocular medications are frequently prescribed for pediatric patients by both pediatricians and ophthalmologists.
  • Commonly treated conditions include bacterial conjunctivitis, nasolacrimal duct obstructions, and ophthalmia neonatorum.
  • Newer antiallergy eye drops are available for seasonal conjunctivitis (hay fever).

Purpose of the Study:

  • To highlight the importance of understanding ocular medication use in pediatric care.
  • To emphasize the need for awareness regarding potential systemic side effects of certain ophthalmic drugs.
  • To guide physicians on safe and effective prescribing practices for pediatric patients.

Main Methods:

  • Review of common ophthalmic medications used in pediatric practice.

Related Experiment Videos

  • Discussion of indications for topical antibiotics, antiallergy drops, dilating drops, and antiglaucoma medications.
  • Emphasis on risk-benefit assessment and monitoring strategies.

    • Main Results:

    • Topical antibiotics are standard for common pediatric eye infections.
    • Dilating and antiglaucoma eye drops, while used by ophthalmologists, carry risks pediatricians must recognize.
    • Systemic side effects are a concern with certain ophthalmic medications.

    Conclusions:

    • Physicians must carefully weigh the risks and benefits before prescribing any ophthalmic medication to children.
    • Utilizing the minimum effective dosage is recommended.
    • Vigilant monitoring for both local and systemic adverse effects in pediatric patients is essential.